Product Overview: Ultima-TriTest 400 Ultima Pharmaceuticals
Ultima-TriTest 400 is a multi-ester testosterone blend developed by Ultima Pharmaceuticals for advanced endocrine research applications. This sophisticated formulation combines three distinct testosterone esters with varying pharmacokinetic profiles to examine sustained androgen receptor activation patterns in controlled laboratory environments. Research institutions studying hormone replacement protocols and anabolic steroid metabolism frequently investigate multi-ester compositions for their unique release characteristics compared to single-ester preparations available at Stroid UK Shop.
Laboratory Applications
Researchers examine Ultima-TriTest 400 across diverse experimental frameworks including comparative pharmacokinetic studies, tissue-selective androgen receptor binding assays, and metabolic pathway analysis. The tri-ester composition enables investigation of both immediate and sustained hormonal effects within the same formulation, making it valuable for studies requiring prolonged observation periods. Scientists working with steroid injection research protocols often evaluate how different ester combinations affect release rates and bioavailability in experimental models. Laboratories studying anabolic mechanisms frequently analyse this compound alongside selective androgen receptor modulators and research peptides to understand comparative receptor activation pathways.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Testosterone tri-ester blend |
| Concentration | 400mg/ml |
| Manufacturer | Ultima Pharmaceuticals |
| Form | Injectable solution |
| CAS Numbers | Verify with supplier |
| Storage | Room temperature, protect from light |
Research Compliance
Ultima-TriTest 400 is manufactured exclusively for in-vitro research applications and laboratory analysis. This compound is not approved for human consumption, therapeutic use, or any clinical applications. Research institutions must ensure proper licensing and safety protocols when handling this material. All experimental procedures should follow institutional guidelines for controlled substance research and maintain appropriate documentation for regulatory compliance.
